BIOCENCE
LIVE

Serial Number

77842866

Owner

Lord, Allan Dale

Attorney

William J. Benman

First Use Date

Jan 17, 2008

Filing Date

Oct 6, 2009

Add to watchlist:

No watchlists yet
View on USPTO

BIOCENCE Trademark

Serial Number: 77842866 • Registration: 4071102

BIOCENCE is a trademark filed by Lord, Allan Dale on October 6, 2009. The trademark is classified under Class 1 (Chemicals). The application is currently registered and active.

Owner Contact Info

Lord, Allan Dale (3 trademarks)

Biocence Technology
Prosper, TX 75078

Entity Type: 01

Trademark Details

Filing Date

October 6, 2009

Registration Date

December 13, 2011

First Use Anywhere

January 17, 2008

First Use in Commerce

January 17, 2008

Published for Opposition

March 29, 2011

Goods & Services

Chemical preservatives for use in the production of a wide variety of chemicals, Preservatives for pharmaceutical preparations; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Bacillus anthracis, Anthrax, Bacillus cereus, B. cereus food poisoning, Clostridium botulinum, Botulism, Clostridium perfringens, Clostridialmyonecrosis (gas gangrene), Clostridium tetani, Tetanus (lockjaw), Corynebacteriuni diphtheria, Diphtheria, Escherichia coli, Diarrhea, Klebsiella pneumonia, Bronchopneumonia, Legionellapneumophila, Legionnaire's disease, Mycobacterium leprae, Leprosy, Mycobacteriumtuberculosis, Tuberculosis, Salmonella species, Salmonella, Salmonella typhi, Typhoid fever, Salmonella typhimurium, Salmonella gastroenteritis, Shigella dysenteriae, Bacillary dysentery, Shigella species, Shigellosis, Yersinia enterocolitica, Yersiniosis, gastroenteritis, Yersiniapestis, Plague, Yersinia pseudotuberculosis, Mesenteric lymphadenitis, Chlamydia, Chlamydiatrachomatis, Trachoma, urethritis, cervicitis, conjunctivitis, Bordetella pertussis, (whooping cough), Brucella species, Undulant fever, Hemophilus influenza, Meningitis, bacterial pneumonia, Hemophilus pertussis, (whooping cough), Neisseria gonorrhoeae, Gonorrhea, pelvicinflammatory disease, Neisseria meningitides, Meningitis, Staphylococcus aureus, Pneumonia, toxic shock syndrome, skin infections, meningitis, Streptococcus pneumonia, Pneumonia, ear infections, meningitis, Streptococcus pyogenes, Strep throat, rheumatic fever, Streptococcusspecies, Scarlet fever, puerperal fever, Listeria monocytogenes, Listeriosis, perinatal septicemia, meningitis, encephalitis, intrauterine infections, Mycoplasma pneumonia, Pneumonia, Rickettsia prowazekii, Epidemic typhus, Brill-Zinsser disease (spread by lice), Rickettsiarickettsii, Rocky Mountain spotted fever (spread by ticks), Rickettsia typhi, Endemic typhus (murine typhus, spread by rat fleas), Campylobacter fetus jejuni, Campylobacteriosis (bacterial diarrheal illness), Spirillum minor, Rat-bite fever, Spirochete Treponema pallidum, Syphilis, Aeromonas hydrophila, Gastroenteritis, septicemia, cellulitis, wound infections, urinary tractinfections, Plesiomonas shigelloides, Gastroenteritis, diarrhea, Vibrio cholerae 01, Epidemiccholera, Vibrio cholerae 01, Gastroenteritis, Vibrio parahemolyticus, V. parahemolyticus associated gastroenteritis, Vibrio vulnificus, Wound infections, gastroenteritis, primarysepticemia, Shigella flexneri, S. dysenteria, Vibrio cholera, Salmonella typhi, Salmonella, Enterotoxigenic Escherichia coli, Enterococcus faecalis, B. anthracis Pseudomonas aeruginosa, Mycobacterium chelonae, Candida albicans, Campylobacter, Mycobacterium tuberculosis, Diarrhoeal diseases, respiratory tract infections, meningitis, sexually transmitted infections, Streptococcus pneumoniae, vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, multi-resistant salmonellae, Clostridium difficile and multi-resistant Mycobacterium, tuberculosis and emerging Infectious Diseases, Virucidal disease and conditions of Influenza, Bird HiNI HIIY, herpes simplex virus type 1 and type 2, AvianFlu, Foot and Mouth disease, Ebola virus, Pox virus, Smallpox virus, Talfan disease virus, Sindbis virus, Adenovirus (Common cold), Bunyavirus, Hantaan, La Crosse, Sin Nombre (Kidney failure), Encephalitis (brain infection), Lung syndrome, Calicivirus Norwalk Gastroenteritis (diarrhea, vomiting), Coronavirus (Corona Common cold), Filovirus Ebola, Marburg Hemorrhagic (fever), Hemorrhagic (fever), Flavivirus Hepatitis C (non-A, non-B): Yellow fever (Hepatitis), Hepatitis, hemorrhage, Hepadnavirus Hepatitis B virus (I-IBV), Hepatitis, liver carcinoma, Herpesvirus, Cytomegalovirus, Epstein-Barr virus (EBV), Herpes simplex type 1, Herpes simplex type 2, Human herpesvirus 8 (HHV8), Varicella-zoster, Birthdefects, Mononucleosis, nasopharyngeal carcinoma, Cold sores, Genital lesions, Kaposi'ssarcoma, Chicken pox, shingles, Orthomyxovirus, Influenza types A and B Flu, Papovavirus, Human papillomavirus (ITPV), Warts, cervical carcinoma, Picornavirus, Coxsackie virus, Echovirus, Hepatitis A, Poliovirus, Rhinovirus, Myocarditis (heart muscle infection), Meningitis, Infectious hepatitis, Poliomyelitis, Common cold, Paramyxovirus, Measles, Mumps, Parainfluenza, Measles, Mumps, ear infections, Parvovirus, B 19 Fifth disease, chronic anemia, Poxvirus Orthopoxvirus Smallpox (eradicated), Reovirus Rotavirus, Diarrhea, Retrovirus, Human immunodeficiency virus (HIV), Human T-cell leukemia virus, (HTLV-l), Acquiredimmunodeficiency syndrome (AIDS), Adult T-cell leukemia, lymphoma, neurologic disease, Rhabdovirus, Rabies, Togavirus, Eastern equine encephalomyelitis, Encephalitis, Rubella, and birth defects

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 27, 2022 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 27, 2022 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 27, 2022 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 27, 2022 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 18, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 13, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 19, 2017 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 19, 2017 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 18, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 6, 2017 E815
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Sep 25, 2012 PRAN
PAPER RECEIVED
Sep 6, 2012 MAIL
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Nov 8, 2011 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Nov 7, 2011 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 3, 2011 CNPR
ASSIGNED TO EXAMINER
Nov 2, 2011 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Oct 27, 2011 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 24, 2011 AITU
USE AMENDMENT FILED
Oct 21, 2011 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 21, 2011 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 24, 2011 NOAM
PUBLISHED FOR OPPOSITION
Mar 29, 2011 PUBO
NOTICE OF PUBLICATION
Mar 9, 2011 NPUB
NOTICE OF REINSTATEMENT MAILED
Feb 25, 2011 MREI
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 24, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2011 CNSA
AMENDMENT FROM APPLICANT ENTERED
Feb 23, 2011 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2011 CRFA
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Feb 22, 2011 RGIA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Feb 16, 2011 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 16, 2011 ABN2
FINAL REFUSAL MAILED
Jul 21, 2010 CNFR
FINAL REFUSAL WRITTEN
Jul 21, 2010 CNFR
AMENDMENT FROM APPLICANT ENTERED
Jul 20, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2010 CRFA
ASSIGNED TO LIE
Jul 20, 2010 ALIE
PAPER RECEIVED
Jul 9, 2010 MAIL
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2010 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2010 COAR
NON-FINAL ACTION MAILED
Jan 8, 2010 CNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2010 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2010 DOCK
NOTICE OF PSEUDO MARK MAILED
Oct 15, 2009 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 14, 2009 NWOS
NEW APPLICATION ENTERED
Oct 9, 2009 NWAP